Novel photoacoustic contrast agent offers safer, cost-effective imaging for tumors

Updated on: July 14,2025

Novel photoacoustic contrast agent offers safer, cost-effective imaging for tumors

Updated on:July 14,2025

Metallic ion Copper and Zinc regulate inflammation and cancer metabolism

Updated on: June 19,2024

Metallic ion Copper and Zinc regulate inflammation and cancer metabolism

Updated on:June 19,2024

BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma

byPerelman School of Medicine at the University of PennsylvaniaMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0An experim

Updated on: December 22,2023

BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma

byPerelman School of Medicine at the University of PennsylvaniaMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0An experim

Updated on:December 22,2023

Danish study finds drug reduces 'forever chemicals' in blood

FEBRUARY 29, 2024Credit: Pixabay/CC0 Public DomainA medication for high cholesterol can drastically cut "forever chemicals" (PFAS)—associated with an increased risk of cancer and banned in E

Updated on: March 15,2024

Danish study finds drug reduces 'forever chemicals' in blood

FEBRUARY 29, 2024Credit: Pixabay/CC0 Public DomainA medication for high cholesterol can drastically cut "forever chemicals" (PFAS)—associated with an increased risk of cancer and banned in E

Updated on:March 15,2024

Scientists learn what women know—and don't know—about breast density and cancer risk

byDartmouth-Hitchcock Medical CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainBreast density is an important risk factor for breast cancer

Updated on: December 22,2023

Scientists learn what women know—and don't know—about breast density and cancer risk

byDartmouth-Hitchcock Medical CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainBreast density is an important risk factor for breast cancer

Updated on:December 22,2023

Health Disparities Persist in Hemophilia Life Expectancy

January 2024Lara C. Pullen, PhDBetween 1999 and 2020, recorded hemophilia death (rHD) rates in the U.S. improved in males across all racial and ethnic groups.Stacey A. Fedewa, PhD, MPH,of

Updated on: February 18,2024

Health Disparities Persist in Hemophilia Life Expectancy

January 2024Lara C. Pullen, PhDBetween 1999 and 2020, recorded hemophilia death (rHD) rates in the U.S. improved in males across all racial and ethnic groups.Stacey A. Fedewa, PhD, MPH,of

Updated on:February 18,2024

IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women

byQueen Mary, University of LondonCredit: CC0 Public DomainThe Queen Mary University of London professor leading an international breast cancer study says anastrozole—rather than tamoxifen—shoul

Updated on: December 22,2023

IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women

byQueen Mary, University of LondonCredit: CC0 Public DomainThe Queen Mary University of London professor leading an international breast cancer study says anastrozole—rather than tamoxifen—shoul

Updated on:December 22,2023

Timing androgen-deprivation therapy with radiation therapy improves outcomes in localized prostate cancer

byUniversity of California, Los AngelesUnadjusted Kaplan-Meier and cumulative incidence curves evaluating the associations between concurrent/adjuvant versus neoadjuvant/concurrent ADT sequencin

Updated on: December 20,2023

Timing androgen-deprivation therapy with radiation therapy improves outcomes in localized prostate cancer

byUniversity of California, Los AngelesUnadjusted Kaplan-Meier and cumulative incidence curves evaluating the associations between concurrent/adjuvant versus neoadjuvant/concurrent ADT sequencin

Updated on:December 20,2023

Time of death or personal autonomy? Cancer patients prefer knowing functional prognosis over life expectancy

byUniversity of TsukubaCredit: AI-generated imageProviding prognostic information is a vital component of cancer patient care. However, the specific information cancer patients prefer to receive

Updated on: January 04,2024

Time of death or personal autonomy? Cancer patients prefer knowing functional prognosis over life expectancy

byUniversity of TsukubaCredit: AI-generated imageProviding prognostic information is a vital component of cancer patient care. However, the specific information cancer patients prefer to receive

Updated on:January 04,2024

Online testing tool identifies people likely to benefit from genetic testing for inherited risk for certain cancers

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainAn online tool developed by researchers and physicians at Dana-Farber Cancer Institute can accurately and rapidly identify people

Updated on: December 18,2023

Online testing tool identifies people likely to benefit from genetic testing for inherited risk for certain cancers

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainAn online tool developed by researchers and physicians at Dana-Farber Cancer Institute can accurately and rapidly identify people

Updated on:December 18,2023

Distinguishing fatal prostate cancer from 'manageable' cancer now possible

byUniversity of YorkScientists at the University of York have found a way of distinguishing between fatal prostate cancer and manageable cancer, which could reduce unnecessary surgeries and radi

Updated on: December 18,2023

Distinguishing fatal prostate cancer from 'manageable' cancer now possible

byUniversity of YorkScientists at the University of York have found a way of distinguishing between fatal prostate cancer and manageable cancer, which could reduce unnecessary surgeries and radi

Updated on:December 18,2023

Immunotherapy effective as first-line treatment for advanced head and neck cancer

byInstitute of Cancer ResearchImmunotherapy on its own is better than aggressive chemotherapy as a first-line treatment for advanced head and neck cancer, according to surprising new data from a

Updated on: December 18,2023

Immunotherapy effective as first-line treatment for advanced head and neck cancer

byInstitute of Cancer ResearchImmunotherapy on its own is better than aggressive chemotherapy as a first-line treatment for advanced head and neck cancer, according to surprising new data from a

Updated on:December 18,2023